全文获取类型
收费全文 | 47845篇 |
免费 | 3223篇 |
国内免费 | 579篇 |
专业分类
耳鼻咽喉 | 281篇 |
儿科学 | 1386篇 |
妇产科学 | 772篇 |
基础医学 | 3499篇 |
口腔科学 | 632篇 |
临床医学 | 3658篇 |
内科学 | 6508篇 |
皮肤病学 | 675篇 |
神经病学 | 1411篇 |
特种医学 | 1278篇 |
外科学 | 5757篇 |
综合类 | 10994篇 |
现状与发展 | 1篇 |
一般理论 | 17篇 |
预防医学 | 8967篇 |
眼科学 | 351篇 |
药学 | 2275篇 |
49篇 | |
中国医学 | 1874篇 |
肿瘤学 | 1262篇 |
出版年
2024年 | 123篇 |
2023年 | 667篇 |
2022年 | 1221篇 |
2021年 | 1601篇 |
2020年 | 1412篇 |
2019年 | 3403篇 |
2018年 | 2986篇 |
2017年 | 1860篇 |
2016年 | 1028篇 |
2015年 | 1099篇 |
2014年 | 2825篇 |
2013年 | 2629篇 |
2012年 | 2727篇 |
2011年 | 2865篇 |
2010年 | 2308篇 |
2009年 | 1949篇 |
2008年 | 1823篇 |
2007年 | 1666篇 |
2006年 | 1525篇 |
2005年 | 1082篇 |
2004年 | 824篇 |
2003年 | 740篇 |
2002年 | 463篇 |
2001年 | 421篇 |
2000年 | 349篇 |
1999年 | 284篇 |
1998年 | 219篇 |
1997年 | 216篇 |
1996年 | 160篇 |
1995年 | 164篇 |
1994年 | 137篇 |
1993年 | 67篇 |
1992年 | 32篇 |
1991年 | 45篇 |
1990年 | 38篇 |
1989年 | 31篇 |
1988年 | 26篇 |
1985年 | 858篇 |
1984年 | 1390篇 |
1983年 | 1118篇 |
1982年 | 1100篇 |
1981年 | 1106篇 |
1980年 | 957篇 |
1979年 | 845篇 |
1978年 | 662篇 |
1977年 | 465篇 |
1976年 | 632篇 |
1975年 | 552篇 |
1974年 | 469篇 |
1973年 | 430篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
961.
962.
963.
964.
965.
966.
Woon H. Chong Biplab K. Saha Scott Beegle 《The American journal of the medical sciences》2021,361(4):526-533
Antisynthetase syndrome (AS) is a rare disease that affects patients with inflammatory myopathies such as polymyositis (PM) and dermatomyositis (DM). In patients with AS, up to 95% of patients develop antisynthetase syndrome-associated interstitial lung disease (AS-ILD). Although AS-ILD commonly occurs in patients with a well-established diagnosis of AS, it can be the first or only manifestation of an occult AS. The frequency of interstitial lung disease (ILD), myopathy, and skin involvement are often dependent on the type of myositis-specific antibodies present. AS-ILD patients who are positive for both anti-Jo-1 and anti-SSA/RO-52 autoantibodies often present with a severe degree of lung restriction on pulmonary function tests and radiologic imaging with an inadequate response toward immunosuppressive therapies. We describe a 65-year-old woman who presents with chronic dyspnea. She was initially diagnosed with corticosteroid-resistant cryptogenic organizing pneumonia based on the radiological findings on her CT chest. Her symptoms did not improve, and she suffered from intolerable corticosteroid-related side effects. Reviews of systems were positive for arthritis and Raynaud's phenomenon. She was found to have elevated inflammatory markers and autoantibodies such as anti-Jo-1, anti-RO-52, and anti-SSA. A diagnosis of AS-ILD resistant to corticosteroid therapy was made. Her lung function improved with combination therapy of mycophenolate and rituximab. Our case highlights that a detailed history and physical exam, compatible radiologic imaging, and autoantibodies are essential for the diagnosis of AS-ILD. 相似文献
967.
968.
Seyed Mehrdad Hamrahian Tibor Fülöp 《The American journal of the medical sciences》2021,361(1):106-110
Potassium is the most important intracellular cation and the kidneys play a pivotal role in potassium homeostasis. Potassium disorder is a common electrolyte abnormality and it increases the risk of death from any cause, particularly cardiovascular events. Hyperkalemia is a common electrolyte abnormality encountered post organ transplantation. The etiology is multifactorial, and includes drugs such as calcineurin inhibitors. In certain regards, the clinical picture of post-transplantation hyperkalemia and hypertension resembles that of Gordon syndrome or familial hyperkalemic hypertension, a disorder characterized by over activity of thiazide-sensitive sodium chloride cotransporter. Effective and safe management of chronic hyperkalemia can be challenging in this special patient population. Despite the significant short-term and long-term side effects, fludrocortisone (a potent synthetic oral mineralocorticoid receptor agonist) has emerged as the default drug of choice for treatment of refractory hyperkalemia in many organ transplant recipients. However, the long-term efficacy and safety of fludrocortisone for management of hyperkalemia in organ transplant recipients remains unknown. This review discusses potassium homeostasis, including the role of the kidneys, and focuses on calcineurin inhibitor-induced hyperkalemia and on the under-appreciated role of thiazide-type diuretic use in management of hyperkalemia and hypertension. We present an illustrative case of post-transplantation hyperkalemia and hypertension with relevant literature. 相似文献
969.